Phenotypic Study of Peripheral Blood Leucocytes in HTLV‐I‐Infected Individuals from Minas Gerais, Brazil
Open Access
- 19 May 2002
- journal article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 55 (6) , 621-628
- https://doi.org/10.1046/j.1365-3083.2002.01087.x
Abstract
The human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) associated with the HTLV-I is a well-defined clinical-pathological entity in which the virus and host immune responses contribute to the pathological mechanism. In this study, flow cytometric analysis of whole peripheral blood leucocytes (PBL) was performed to evaluate the immunological status of HTLV-I-infected individuals in an effort to better understand the role of the immune system in the development of HAM/TSP. We have evaluated three groups of infected patients including asymptomatic (AS = 18), ambulatory/oligosymptomatic (AM = 14) and hospitalized HAM/TSP individuals (HO = 42). Noninfected healthy blood donors were used for the control group (NI = 32). Our results demonstrated that the HO group presents an increased percentage of circulating T cells and a decreased percentage of B and natural killer (NK) cells, leading to the highest T/B-cell ratio in comparison with the other groups. Interestingly, while an increased percentage of activated CD4+HLA-DR+ T lymphocytes was observed in both AM and HO, only HO presented higher percentage of activated CD8+HLA-DR+ in combination with the highest CD18 surface expression. This was true for all cell populations analysed, including T lymphocytes, monocytes and neutrophils. Moreover, the HO group was distinguished by a dramatic decrease in the percentage of CD8+CD28+ lymphocytes. Taken together, these findings demonstrate a potent cellular immune activation response involving primarily CD8+ T cells that is concomitant with disease progression in HAM/TSP. We also show that an upregulation of CD18 expression, a hallmark for increased cell migratory potential, might play a critical role in the development/maintenance of HAM/TSP.Keywords
This publication has 24 references indexed in Scilit:
- The past, the present and the future of HAM/TSP researchJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Chagasic Patients Lack CD28 Expression on Many of Their Circulating T LymphocytesScandinavian Journal of Immunology, 1996
- HTLV-I-Induced T-Cell ActivationJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Cerebrospinal fluid interferon-gamma is increased in HTLV-I-associated myelopathyJournal of Neuroimmunology, 1993
- Increased replication of HTLV‐I in HTLV‐I–associated myelopathyAnnals of Neurology, 1989
- Immunological findings in neurological diseases associated with antibodies to HTLV-I: Activated lymphocytes in tropical spastic paraparesisAnnals of Neurology, 1988
- NECROPSY FINDINGS IN HTLV-I ASSOCIATED MYELOPATHYThe Lancet, 1987
- HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITYThe Lancet, 1986
- ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESISPublished by Elsevier ,1985
- The virus of Japanese adult T-cell leukaemia is a member of the human T-cell leukaemia virus groupNature, 1982